Share
Biosimilar Clinical Development: Scientific Considerations and new Methodologies (Chapman & Hall (in English)
Kerry B. Barker (Editor), Sandeep M. Menon (Editor), Ralph B. D'agostino (Editor), Siyan Xu (Editor), Bo Jin (Editor) (Author)
·
Routledge
· Paperback
Biosimilar Clinical Development: Scientific Considerations and new Methodologies (Chapman & Hall (in English) - Kerry B. Barker (Editor), Sandeep M. Menon (Editor), Ralph B. D'agostino (Editor), Siyan Xu (Editor), Bo Jin (Editor)
$ 49.59
$ 61.99
You save: $ 12.40
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Wednesday, July 03 and
Friday, July 12.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Biosimilar Clinical Development: Scientific Considerations and new Methodologies (Chapman & Hall (in English)"
Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.